Alar Pharmaceuticals Inc.

NT$73.80As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6785Healthcare
Country Taiwan
PE (Fwd) •••
TSR 6Y CAGR 7.08%
Div yield 0.14%
ROE (2.99%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.18
PE TTM —
TSR TTM (72.02%)
Mkt cap NT$4.930B
ROIC (4.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$79
6.68%
(80.48%)
Hold 9|0|12|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.38
1.32
1.37
1.31
7.55%
(0.40%)
4.25%
(5.72%)
RevenueNT$M
225.0
238.3
249.7
250.4
(3.26%)
0.49%
8.40%
11.72%
Peers (US$148.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
4.152
(2.436)
(2.006)
EBIT/Intx
0.910
0.206
0.207
Own earn%
48.27
(80.18)
(70.09)
Sh yield%
16.48
33.23
32.89
Owners
Insiders/Inst%
3.54
52.59
Short interest%
4.65
SBC / revenue%
5.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
11–21
$1 testx
0.0
Incr. ROIC%
14